Menopause Market 2028 By Hormonal Treatment, Non-Hormonal Treatment, End User, and Geography | The Insight Partners

    Menopause Market Forecast to 2028 - COVID-19 Impact and Global Analysis byHormonal Treatment (Estrogen, Progesterone, and Combination); Non-Hormonal Treatment (Anti-Depressants, Anti-Anxiety, and Anti-Migraine); End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Geography

    Report Code: TIPRE00023677 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET OVERVIEW

    Menopause is the end of the fertility stage in women, which occurs at the age of 40 in almost 80% of women. Menopause reduces estrogen production and increases gonadotropin, which leads in the termination of their menstrual flow and cycle. Few of the symptoms that are observed during menopause are hot flashes, formication, and migraine.

    MARKET SCOPE

    The "Global Menopause Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Menopause market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Menopause market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

      - Based on hormonal treatment, the global Menopause market is segmented into estrogen, progesterone, combination.
      - On the basis of non-hormonal treatment, the market is segmented into anti-depressants, anti-anxiety, anti-migraine
      - On the basis of end use, the market is segmented into hospitals and clinics, academic and research, institutes, others.

    MARKET DYNAMICS
    Drivers:

      - Rise in the incidences of several menopausal symptoms.
      - Rise in the awareness about menopause and its treatment.
      - Increasing research supporting advantages of dietary supplements.

    Restraints:

      - The lack of advanced healthcare infrastructure in developing countries is the major restraining factor for this market.

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Menopause market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

    The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Menopause market in these regions.

    IMPACT OF COVID-19 ON MENOPAUSE MARKET

    COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the Menopause market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Menopause market are anticipated to lucrative growth opportunities in the future with the rising demand for Menopause in the global market.

    The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Menopause market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

      - Merck & Co.Inc.
      - Novartis AG
      - Novo Nordisk A/S
      - Pfizer Inc.
      - Allergan plc
      - Emcure Pharmaceuticals Ltd.
      - Eli Lilly and Company
      - Cipla Inc.
      - Teva Pharmaceutical Industries Ltd.
      - Glenmark Pharmaceuticals Ltd
    The Insight Partner's dediMenopauseed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Menopause Market - By Hormonal Treatment
    1.3.2 Menopause Market - By Non-Hormonal Treatment
    1.3.3 Menopause Market - By End User
    1.3.4 Menopause Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. MENOPAUSE MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. MENOPAUSE MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. MENOPAUSE MARKET - GLOBAL MARKET ANALYSIS
    6.1. MENOPAUSE - GLOBAL MARKET OVERVIEW
    6.2. MENOPAUSE - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING
    7. MENOPAUSE MARKET - REVENUE AND FORECASTS TO 2028 - HORMONAL TREATMENT
    7.1. OVERVIEW
    7.2. HORMONAL TREATMENT MARKET FORECASTS AND ANALYSIS
    7.3. ESTROGEN
    7.3.1. Overview
    7.3.2. Estrogen Market Forecast and Analysis
    7.4. PROGESTERONE
    7.4.1. Overview
    7.4.2. Progesterone Market Forecast and Analysis
    7.5. COMBINATION
    7.5.1. Overview
    7.5.2. Combination Market Forecast and Analysis
    8. MENOPAUSE MARKET - REVENUE AND FORECASTS TO 2028 - NON-HORMONAL TREATMENT
    8.1. OVERVIEW
    8.2. NON-HORMONAL TREATMENT MARKET FORECASTS AND ANALYSIS
    8.3. ANTI-DEPRESSANTS
    8.3.1. Overview
    8.3.2. Anti-Depressants Market Forecast and Analysis
    8.4. ANTI-ANXIETY
    8.4.1. Overview
    8.4.2. Anti-Anxiety Market Forecast and Analysis
    8.5. ANTI-MIGRAINE
    8.5.1. Overview
    8.5.2. Anti-Migraine Market Forecast and Analysis
    9. MENOPAUSE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
    9.1. OVERVIEW
    9.2. END USER MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITALS AND CLINICS
    9.3.1. Overview
    9.3.2. Hospitals and Clinics Market Forecast and Analysis
    9.4. ACADEMIC AND RESEARCH INSTITUTES
    9.4.1. Overview
    9.4.2. Academic and Research Institutes Market Forecast and Analysis
    9.5. OTHERS
    9.5.1. Overview
    9.5.2. Others Market Forecast and Analysis
    10. MENOPAUSE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Menopause Market Overview
    10.1.2 North America Menopause Market Forecasts and Analysis
    10.1.3 North America Menopause Market Forecasts and Analysis - By Hormonal Treatment
    10.1.4 North America Menopause Market Forecasts and Analysis - By Non-Hormonal Treatment
    10.1.5 North America Menopause Market Forecasts and Analysis - By End User
    10.1.6 North America Menopause Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Menopause Market
    10.1.6.1.1 United States Menopause Market by Hormonal Treatment
    10.1.6.1.2 United States Menopause Market by Non-Hormonal Treatment
    10.1.6.1.3 United States Menopause Market by End User
    10.1.6.2 Canada Menopause Market
    10.1.6.2.1 Canada Menopause Market by Hormonal Treatment
    10.1.6.2.2 Canada Menopause Market by Non-Hormonal Treatment
    10.1.6.2.3 Canada Menopause Market by End User
    10.1.6.3 Mexico Menopause Market
    10.1.6.3.1 Mexico Menopause Market by Hormonal Treatment
    10.1.6.3.2 Mexico Menopause Market by Non-Hormonal Treatment
    10.1.6.3.3 Mexico Menopause Market by End User
    10.2. EUROPE
    10.2.1 Europe Menopause Market Overview
    10.2.2 Europe Menopause Market Forecasts and Analysis
    10.2.3 Europe Menopause Market Forecasts and Analysis - By Hormonal Treatment
    10.2.4 Europe Menopause Market Forecasts and Analysis - By Non-Hormonal Treatment
    10.2.5 Europe Menopause Market Forecasts and Analysis - By End User
    10.2.6 Europe Menopause Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Menopause Market
    10.2.6.1.1 Germany Menopause Market by Hormonal Treatment
    10.2.6.1.2 Germany Menopause Market by Non-Hormonal Treatment
    10.2.6.1.3 Germany Menopause Market by End User
    10.2.6.2 France Menopause Market
    10.2.6.2.1 France Menopause Market by Hormonal Treatment
    10.2.6.2.2 France Menopause Market by Non-Hormonal Treatment
    10.2.6.2.3 France Menopause Market by End User
    10.2.6.3 Italy Menopause Market
    10.2.6.3.1 Italy Menopause Market by Hormonal Treatment
    10.2.6.3.2 Italy Menopause Market by Non-Hormonal Treatment
    10.2.6.3.3 Italy Menopause Market by End User
    10.2.6.4 Spain Menopause Market
    10.2.6.4.1 Spain Menopause Market by Hormonal Treatment
    10.2.6.4.2 Spain Menopause Market by Non-Hormonal Treatment
    10.2.6.4.3 Spain Menopause Market by End User
    10.2.6.5 United Kingdom Menopause Market
    10.2.6.5.1 United Kingdom Menopause Market by Hormonal Treatment
    10.2.6.5.2 United Kingdom Menopause Market by Non-Hormonal Treatment
    10.2.6.5.3 United Kingdom Menopause Market by End User
    10.2.6.6 Rest of Europe Menopause Market
    10.2.6.6.1 Rest of Europe Menopause Market by Hormonal Treatment
    10.2.6.6.2 Rest of Europe Menopause Market by Non-Hormonal Treatment
    10.2.6.6.3 Rest of Europe Menopause Market by End User
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Menopause Market Overview
    10.3.2 Asia-Pacific Menopause Market Forecasts and Analysis
    10.3.3 Asia-Pacific Menopause Market Forecasts and Analysis - By Hormonal Treatment
    10.3.4 Asia-Pacific Menopause Market Forecasts and Analysis - By Non-Hormonal Treatment
    10.3.5 Asia-Pacific Menopause Market Forecasts and Analysis - By End User
    10.3.6 Asia-Pacific Menopause Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Menopause Market
    10.3.6.1.1 Australia Menopause Market by Hormonal Treatment
    10.3.6.1.2 Australia Menopause Market by Non-Hormonal Treatment
    10.3.6.1.3 Australia Menopause Market by End User
    10.3.6.2 China Menopause Market
    10.3.6.2.1 China Menopause Market by Hormonal Treatment
    10.3.6.2.2 China Menopause Market by Non-Hormonal Treatment
    10.3.6.2.3 China Menopause Market by End User
    10.3.6.3 India Menopause Market
    10.3.6.3.1 India Menopause Market by Hormonal Treatment
    10.3.6.3.2 India Menopause Market by Non-Hormonal Treatment
    10.3.6.3.3 India Menopause Market by End User
    10.3.6.4 Japan Menopause Market
    10.3.6.4.1 Japan Menopause Market by Hormonal Treatment
    10.3.6.4.2 Japan Menopause Market by Non-Hormonal Treatment
    10.3.6.4.3 Japan Menopause Market by End User
    10.3.6.5 South Korea Menopause Market
    10.3.6.5.1 South Korea Menopause Market by Hormonal Treatment
    10.3.6.5.2 South Korea Menopause Market by Non-Hormonal Treatment
    10.3.6.5.3 South Korea Menopause Market by End User
    10.3.6.6 Rest of Asia-Pacific Menopause Market
    10.3.6.6.1 Rest of Asia-Pacific Menopause Market by Hormonal Treatment
    10.3.6.6.2 Rest of Asia-Pacific Menopause Market by Non-Hormonal Treatment
    10.3.6.6.3 Rest of Asia-Pacific Menopause Market by End User
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Menopause Market Overview
    10.4.2 Middle East and Africa Menopause Market Forecasts and Analysis
    10.4.3 Middle East and Africa Menopause Market Forecasts and Analysis - By Hormonal Treatment
    10.4.4 Middle East and Africa Menopause Market Forecasts and Analysis - By Non-Hormonal Treatment
    10.4.5 Middle East and Africa Menopause Market Forecasts and Analysis - By End User
    10.4.6 Middle East and Africa Menopause Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Menopause Market
    10.4.6.1.1 South Africa Menopause Market by Hormonal Treatment
    10.4.6.1.2 South Africa Menopause Market by Non-Hormonal Treatment
    10.4.6.1.3 South Africa Menopause Market by End User
    10.4.6.2 Saudi Arabia Menopause Market
    10.4.6.2.1 Saudi Arabia Menopause Market by Hormonal Treatment
    10.4.6.2.2 Saudi Arabia Menopause Market by Non-Hormonal Treatment
    10.4.6.2.3 Saudi Arabia Menopause Market by End User
    10.4.6.3 U.A.E Menopause Market
    10.4.6.3.1 U.A.E Menopause Market by Hormonal Treatment
    10.4.6.3.2 U.A.E Menopause Market by Non-Hormonal Treatment
    10.4.6.3.3 U.A.E Menopause Market by End User
    10.4.6.4 Rest of Middle East and Africa Menopause Market
    10.4.6.4.1 Rest of Middle East and Africa Menopause Market by Hormonal Treatment
    10.4.6.4.2 Rest of Middle East and Africa Menopause Market by Non-Hormonal Treatment
    10.4.6.4.3 Rest of Middle East and Africa Menopause Market by End User
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Menopause Market Overview
    10.5.2 South and Central America Menopause Market Forecasts and Analysis
    10.5.3 South and Central America Menopause Market Forecasts and Analysis - By Hormonal Treatment
    10.5.4 South and Central America Menopause Market Forecasts and Analysis - By Non-Hormonal Treatment
    10.5.5 South and Central America Menopause Market Forecasts and Analysis - By End User
    10.5.6 South and Central America Menopause Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Menopause Market
    10.5.6.1.1 Brazil Menopause Market by Hormonal Treatment
    10.5.6.1.2 Brazil Menopause Market by Non-Hormonal Treatment
    10.5.6.1.3 Brazil Menopause Market by End User
    10.5.6.2 Argentina Menopause Market
    10.5.6.2.1 Argentina Menopause Market by Hormonal Treatment
    10.5.6.2.2 Argentina Menopause Market by Non-Hormonal Treatment
    10.5.6.2.3 Argentina Menopause Market by End User
    10.5.6.3 Rest of South and Central America Menopause Market
    10.5.6.3.1 Rest of South and Central America Menopause Market by Hormonal Treatment
    10.5.6.3.2 Rest of South and Central America Menopause Market by Non-Hormonal Treatment
    10.5.6.3.3 Rest of South and Central America Menopause Market by End User
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MENOPAUSE MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Middle East and Africa
    11.5 South and Central America
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. MENOPAUSE MARKET, KEY COMPANY PROFILES
    13.1. MERCK AND CO.INC.
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. NOVARTIS AG
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. NOVO NORDISK A/S
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. PFIZER INC.
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. ALLERGAN PLC
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. EMCURE PHARMACEUTICALS LTD.
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. ELI LILLY AND COMPANY
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. CIPLA INC.
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. GLENMARK PHARMACEUTICALS LTD
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    1. Merck & Co.Inc.
    2. Novartis AG
    3. Novo Nordisk A/S
    4. Pfizer Inc.
    5. Allergan plc
    6. Emcure Pharmaceuticals Ltd.
    7. Eli Lilly and Company
    8. Cipla Inc.
    9. Teva Pharmaceutical Industries Ltd.
    10. Glenmark Pharmaceuticals Ltd
    11. Abbott Laboratories
    TIPRE00023677
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount